Kusuri No Aoki Holdings Co., Ltd.

3549.T
Pharmaceutical Retailers
2026/02/17 Updated
Market Cap: $2.8B (¥421.2B)
Stock Price: $29.00 (¥4,435)
Exchange Rate: 1 USD = ¥152.91

Notice Regarding Withdrawal of Proposal for Extraordinary General Meeting of Shareholders and Change of Candidate for Independent Committee Member

The proposal for the election of a director scheduled for the extraordinary general meeting of shareholders on February 17, 2026, has been withdrawn due to health reasons, and the candidate for the independent committee member has been changed from Mr. Yoshiki Nishii to Mr. Shinichi Morioka.

Importance:
Page Updated: February 16, 2026
IR Disclosure Date: February 16, 2026

Key Figures

  • Extraordinary General Meeting Date: 2026-02-17
  • Withdrawn Proposal: Proposal No.1 “Election of one director”
  • Change of Independent Committee Member Candidate: Mr. Yoshiki Nishii → Mr. Shinichi Morioka

AI要約

Regarding the Withdrawal of Proposal for the Extraordinary General Meeting of Shareholders

The proposal No.1 “Election of one director,” which was scheduled to be submitted at the extraordinary general meeting of shareholders on February 17, 2026, has been withdrawn by resolution of the board of directors due to the withdrawal of Mr. Yoshiki Nishii, the director candidate, for health reasons. Consequently, this proposal will no longer be subject to deliberation at the extraordinary general meeting of shareholders.

Regarding the Change of Candidate for Independent Committee Member

Regarding the candidate for independent committee member related to proposal No.2 “Introduction of a policy in response to large-scale acquisition of company shares (takeover defense policy),” Mr. Nishii was scheduled to assume the committee member position contingent on approval of proposal No.1. However, following the withdrawal of proposal No.1, the board of directors resolved to appoint Mr. Shinichi Morioka, a lawyer with high expertise and independence, as the new candidate for independent committee member. Mr. Morioka’s suitability has been confirmed as the company’s alternate auditor.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.